HIGHLIGHTS
- who: Silvia La Monica from the DepartmentUniversity of have published the research work: EGFR Signaling in Non-Small Cell Lung Cancer: From Molecular Mechanisms to Therapeutic Opportunities, in the Journal: Cells 2022, 11, 0. of 13/04/2022
SUMMARY
Copyright: 2 of 3 authors suggest that the targeted NGS of ctDNA could be an important tool to monitor the response of patients with NSCLC to the EGFR-TKI treatment. It summarises the currently approved targeted treatment options and describes in detail the complex patterns of resistance, including the intrinsic and acquired resistance mechanisms . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.